Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $145.21
Change $0.57 | 0.39%
As Of 12/19/14

Investment Objectives

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.

Net Asset Value

Net Asset Value $145.21
Change $0.57 | 0.39%


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Funds Distributors, LLC.


Volume 115,338
Last Sale Price $145.49
52-Week Range $145.21 / $108.79
Shares Outstanding 3,300,000
Total Net Assets $479,188,856.09

Market Close

Market Price $145.49
Premium / Discount $0.28
Change $0.96 | 0.66%
High / Low $146.02 / $144.65

Historical Market Closes to NAV

  Days % of Total Days
Premium 1015 49.58%
Discount 922 45.04%
Equal to NAV 110 5.37%
Total 2,047 100%


Number of Stocks 55
Return on Equity (quarterly 9/30/14) 17.27%
Price to Earning (P/E) 26.73
Price to Book (P/B) 3.52
Dividend Amount $0.15
Ex-Dividend Date N/A


As of 11/28/14
Standard Deviation Sharpe Ratio Beta R-Squared
10.34 2.97 1.01 99.53

Risk Definitions

Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.


as of 12/19/2014
Total Assets $479,188,856
Number of Stocks 55
Percent Stock 99.84%
Percent Cash / Other 0.16%

Sectors / Industries

as of 12/19/14


as of 12/19/14

Security Name Ticker Shares
% of Net Assets Sector / Industry
EDWARDS LIFESCIENCES CORP EW 77,777 $10,360,674.17 2.16% Health Care Equipment & Supplies
CELGENE CORPORATION CELG 84,709 $9,926,200.62 2.07% Biotechnology
VERTEX PHARMACEUTICALS VRTX 83,373 $9,913,049.70 2.07% Biotechnology
CAREFUSION CORP CFN 167,115 $9,884,852.25 2.06% Health Care Equipment & Supplies
ALLERGAN INC AGN 45,807 $9,739,942.41 2.03% Pharmaceuticals
REGENERON PHARMACEUTICALS REGN 22,404 $9,580,846.56 2.00% Biotechnology
AMGEN INC. AMGN 56,224 $9,567,638.08 2.00% Biotechnology
BECTON DICKINSON & CO BDX 68,175 $9,531,546.75 1.99% Health Care Equipment & Supplies
MYLAN INC. MYL 164,738 $9,474,082.38 1.98% Pharmaceuticals
BRISTOL MYERS SQUIBB CO BMY 154,250 $9,455,525.00 1.97% Pharmaceuticals
PATTERSON COS INC PDCO 191,095 $9,369,387.85 1.96% Health Care Providers & Services
ZOETIS INC ZTS 214,283 $9,323,453.33 1.95% Pharmaceuticals
HOSPIRA INC HSP 147,309 $9,230,381.94 1.93% Pharmaceuticals
UNITEDHEALTH GROUP INC. UNH 89,962 $9,220,205.38 1.92% Health Care Providers & Services
AMERISOURCEBERGEN CORP ABC 100,548 $9,218,240.64 1.92% Health Care Providers & Services
ABBVIE INC-W/I ABBV 133,944 $9,069,348.24 1.89% Pharmaceuticals
ALEXION PHARMACEUTICALS I ALXN 47,647 $9,030,535.91 1.88% Biotechnology
PERRIGO COMPANY PRGO 53,653 $9,021,215.42 1.88% Pharmaceuticals
MALLINCKRODT PLC MNK 89,887 $8,945,554.24 1.87% Pharmaceuticals
DENTSPLY INTERNATIONAL XRAY 165,835 $8,905,339.50 1.86% Health Care Equipment & Supplies
C.R. BARD, INC. BCR 52,407 $8,882,986.50 1.85% Health Care Equipment & Supplies
MEDTRONIC, INC. MDT 118,922 $8,873,959.64 1.85% Health Care Equipment & Supplies
HUMANA, INC. HUM 60,445 $8,853,379.15 1.85% Health Care Providers & Services
STRYKER CORP SYK 92,888 $8,804,853.52 1.84% Health Care Equipment & Supplies
COVIDIEN PLC COV 85,502 $8,798,155.80 1.84% Health Care Equipment & Supplies
ACTAVIS PLC ACT 33,080 $8,779,101.20 1.83% Pharmaceuticals
CIGNA CORPORATION CI 83,976 $8,778,011.28 1.83% Health Care Providers & Services
WATERS CORPORATION WAT 76,168 $8,766,175.12 1.83% Life Sciences Tools & Services
BIOGEN IDEC, INC. BIIB 23,977 $8,647,784.59 1.80% Biotechnology
ELI LILLY & COMPANY LLY 118,779 $8,599,599.60 1.79% Pharmaceuticals
INTUITIVE SURGICAL, INC. ISRG 16,123 $8,576,791.08 1.79% Health Care Equipment & Supplies
AETNA INC AET 94,317 $8,567,756.28 1.79% Health Care Providers & Services
CARDINAL HEALTH, INC. CAH 102,833 $8,539,252.32 1.78% Health Care Providers & Services
EXPRESS SCRIPTS HLDGS ESRX 105,141 $8,513,266.77 1.78% Health Care Providers & Services
MCKESSON CORPORATION MCK 40,280 $8,503,913.60 1.77% Health Care Providers & Services
CERNER CORPORATION CERN 131,961 $8,494,329.57 1.77% Health Care Technology
ZIMMER HOLDINGS INC ZMH 73,880 $8,489,550.80 1.77% Health Care Equipment & Supplies
PFIZER INC PFE 263,427 $8,413,858.38 1.76% Pharmaceuticals
ABBOTT LABORATORIES ABT 182,201 $8,390,356.05 1.75% Health Care Equipment & Supplies
ANTHEM INC ANTM 65,351 $8,361,660.45 1.74% Health Care Providers & Services
ST. JUDE MEDICAL INC. STJ 122,900 $8,255,193.00 1.72% Health Care Equipment & Supplies
QUEST DIAGNOSTICS, INC. DGX 123,802 $8,213,024.68 1.71% Health Care Providers & Services
BOSTON SCIENTIFIC CORP BSX 620,217 $8,155,853.55 1.70% Health Care Equipment & Supplies
GILEAD SCIENCES, INC. GILD 74,787 $8,110,650.15 1.69% Biotechnology
THERMO FISHER SCIENTIFIC TMO 62,886 $8,077,706.70 1.69% Life Sciences Tools & Services
VARIAN MEDICAL SYSTEMS IN VAR 90,852 $7,998,610.08 1.67% Health Care Equipment & Supplies
DAVITA, INC DVA 104,668 $7,948,487.92 1.66% Health Care Providers & Services
JOHNSON & JOHNSON JNJ 74,134 $7,824,843.70 1.63% Pharmaceuticals
MERCK & COMPANY, INC. MRK 130,187 $7,756,541.46 1.62% Pharmaceuticals
BAXTER INTERNATIONAL BAX 103,779 $7,729,459.92 1.61% Health Care Equipment & Supplies
LABORATORY CORP OF AMERIC LH 72,899 $7,712,714.20 1.61% Health Care Providers & Services
UNIVERSAL HEALTH SERVICES UHS 69,402 $7,625,197.74 1.59% Health Care Providers & Services
PERKINELMER PKI 173,555 $7,596,502.35 1.59% Life Sciences Tools & Services
AGILENT TECHNOLOGIES, INC A 180,755 $7,479,641.90 1.56% Life Sciences Tools & Services
TENET HEALTHCARE CORP THC 125,999 $6,533,048.15 1.36% Health Care Providers & Services


Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

“Standard & Poor’s®”, “S&P®”, “S&P 500®”, “Standard & Poor’s 500”, “500”, “S&P MidCap 400” and “S&P SmallCap 600” are trademarks of Standard & Poor’s, LLC and have been licensed for use by Guggenheim Investments and its affiliates. Citigroup is a trademark of Citigroup Global Markets Inc. and has been licensed for use by Standard & Poor’s. The product is not sponsored, endorsed, sold or promoted by Standard & Poor’s, and neither Standard & Poor’s nor Citigroup Global Markets Inc. makes no representation regarding the advisability of investing in the product.

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.


Subscribe to Perspectives


©2014 Guggenheim Investments. All Rights Reserved.

• Not FDIC Insured • No Bank Guarantee • May Lose Value